Treatment of Female Stress Urinary Incontinence
First-Line Conservative Treatment Options
- The American College of Physicians recommends pelvic floor muscle training (PFMT) as the first-line treatment for women with stress urinary incontinence, with up to 70% improvement in symptoms when properly performed, and it is most effective when combined with bladder training for women with mixed urinary incontinence 1
- The European Association of Urology suggests that adding dynamic lumbopelvic stabilization (DLS) to PFMT can improve outcomes, with better day and night urine control and quality of life compared to PFMT alone 2
- Weight loss and exercise are strongly recommended for obese women with stress urinary incontinence, as part of a comprehensive treatment plan 1
- Continence pessaries and vaginal inserts can be used as alternative conservative options for women who prefer non-surgical approaches, with varying degrees of success 3
Surgical Treatment Options
- Midurethral slings (MUS) are the most extensively studied surgical option with strong evidence supporting their use, and are recommended by the European Association of Urology for women with stress urinary incontinence 4, 3
- The American Urological Association suggests that retropubic midurethral sling (RMUS) has better long-term outcomes for severe stress urinary incontinence cases, while transobturator midurethral sling (TMUS) has a lower risk of bladder perforation but a higher risk of groin pain 5
- Single-incision slings (SIS) are now recognized as a viable option with emerging long-term data, and may be considered for women who are candidates for surgical treatment 2
- Autologous fascia pubovaginal sling (PVS) is an excellent alternative for patients concerned about mesh complications, with 85-92% success rates at 3-15 years follow-up, and is recommended by the American Urological Association for women with stress urinary incontinence 3, 5
Risk-Benefit Considerations
- Pre-operative counseling regarding MUS mesh complications results in reduced patient concern, greater willingness to proceed, and higher satisfaction, and is recommended by the European Association of Urology as part of the treatment process 6, 5
Treatment Algorithm
- The American College of Physicians recommends starting with supervised PFMT for at least 3 months, with the addition of weight loss programs for obese patients and bladder training for women with mixed urinary incontinence, before considering surgical options 1
- If conservative treatment fails, surgical options should be considered based on the severity of symptoms, presence of prolapse, patient concerns about mesh, and desire for less invasive procedures, with midurethral slings being the most effective surgical option for most women 4, 3, 1
Urinary Incontinence Pessary Mechanism and Effectiveness
Mechanism of Action
- Continence pessaries work by mechanically supporting the urethra and bladder neck, restoring the urethrovesical angle and providing compression to prevent urinary leakage during activities that increase intra-abdominal pressure, as recommended by the American Urological Association 7, 8
Clinical Application and Effectiveness
- The European Urology guidelines position pessaries alongside pelvic floor muscle training as key conservative modalities before considering surgical intervention, with a focus on women with stress urinary incontinence or stress-predominant mixed urinary incontinence 9, 10
- Continence pessaries are appropriate first-line conservative treatment options for women with stress urinary incontinence or stress-predominant mixed urinary incontinence who prefer non-surgical management, according to the American Urological Association 7, 8
- The American Urological Association and the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction acknowledge that ring pessaries are the most commonly used type for incontinence, though there are no comparative data on different pessary types for stress urinary incontinence management 7, 8
- Pessaries are particularly suitable for women not bothered enough to pursue surgical therapy, as stated by the American Urological Association 7
Limitations and Caveats
- A critical limitation is that current guidelines classify pessary recommendations as "Expert Opinion" rather than evidence-based recommendations, reflecting the lack of high-quality comparative trials, as noted by the American Urological Association 7, 8
Management of Postpartum Stress Urinary Incontinence
Diagnostic Evaluation
In women with recent vaginal delivery who report continuous leakage without urge, stress urinary incontinence should be suspected, and a urinalysis is recommended to exclude urinary‑tract infection as a contributing factor. American College of Physicians – strong recommendation, high‑quality evidence. 11
Routine invasive urodynamic testing is not required at the initial assessment; it should be reserved for cases in which conservative therapy fails or when surgical planning is considered. European Association of Urology – conditional recommendation, moderate‑quality evidence. 12
First‑Line Conservative Treatment
Supervised pelvic‑floor muscle training (PFMT) is the definitive first‑line therapy for postpartum stress urinary incontinence, with up to 70 % of patients achieving symptom improvement when performed correctly under professional guidance. American College of Physicians – strong recommendation, high‑quality evidence. 11
For patients with obesity, a structured weight‑loss and exercise program should be offered concurrently, as moderate‑quality evidence supports its benefit in reducing incontinence severity. American College of Physicians – moderate recommendation, moderate‑quality evidence. 11
Pharmacologic Therapy
Systemic pharmacologic agents (e.g., antimuscarinics, β3‑agonists) are not recommended for stress urinary incontinence; the American College of Physicians issues a strong recommendation against their use based on low‑quality evidence showing lack of efficacy. 11
Pharmacologic treatments are reserved for urgency urinary incontinence and should not be employed in stress urinary incontinence management. American College of Physicians – strong recommendation, low‑quality evidence. 11
Stress Urinary Incontinence: Evidence‑Based Diagnosis and Surgical Management
Diagnosis
- Stress urinary incontinence (SUI) is confirmed when involuntary urine leakage from the urethral meatus occurs simultaneously with increased abdominal pressure during coughing or Valsalva maneuver. 13
- A thorough history should document the frequency, bother, severity of leakage episodes, impact on daily activities, and patient treatment expectations. 14
- The cough stress test—observing urine leakage while the patient coughs—is essential for a definitive diagnosis. 13
When Additional Urodynamic Testing Is Indicated
- Prior failed anti‑incontinence surgery. 14
- Co‑existing overactive bladder symptoms. 14
- Suspected or known neurogenic bladder dysfunction. 14
- A negative cough stress test despite persistent symptoms. 14
- Presence of grade III or higher pelvic organ prolapse. 14
First‑Line Conservative Management
(No cited efficacy data for pelvic‑floor muscle training were provided in the referenced sources; therefore, no bullet point is included for this topic.)
Surgical Management
- Mid‑urethral slings (MUS) achieve an overall cure rate of approximately 84 % at 12–23 months post‑operation. 14
- Retropubic mid‑urethral slings carry a higher risk of intra‑operative bladder perforation, necessitating routine cystoscopic verification. 13
- Autologous fascia pubovaginal slings provide a cure rate of about 90 % at 12–23 months. 14
- Open Burch colposuspension results in an 82 % cure rate at 12–23 months. 14
- Urethral bulking agents have a lower efficacy, with a 48 % cure rate at 12–23 months and diminishing effectiveness after 1–2 years. 14
Pre‑operative Counseling
- Clinicians must discuss the specific risks and benefits of synthetic mesh, reference FDA safety communications, and present alternative surgical options before selecting a MUS procedure. 13
- Reported success rates for MUS vary widely (51 %–88 %) with durability demonstrated beyond 15 years of follow‑up. 13